Insights

Strategic Partnerships ScaleReady operates as a joint venture backed by Bio-Techne and Wilson Wolf with an established partner ecosystem including MaxCyte, Verismo Therapeutics, and BrainChild Bio; this presents a clear sales path to cross-sell the ScaleReady platform through existing client bases and co-marketing opportunities, as well as to explore channel partnerships for CGT manufacturing solutions.

Grant-Funded Demand The G-Rex Grant program and related free initiatives signal strong demand for scalable CGT manufacturing support; position ScaleReady as a grant-enabled partner that helps clients access funding, accelerate project timelines, and bundle the G-Rex based platform with GMP cytokine components to close deals.

CGT Efficiency Upsell ScaleReady emphasizes simple, scalable, and versatile manufacturing with G-Rex optimized ProPak GMP Cytokines; target high-growth CGT developers seeking closed-system, efficient manufacturing to raise deal size and expand from pilot to commercial production.

Growth Through Events Recent launches of LEAN Cell & Gene event series and partnerships with Hanson Wade provide a lead-generation channel to reach therapeutic developers; leverage these events to demonstrate ROI, share customer success stories, and accelerate pipeline for ScaleReady offerings.

Data-Driven Outreach With Pardot and HubSpot in its tech stack, ScaleReady can be targeted using marketing automation to identify similarly sized biotech firms, nurture prospects with tailored demos and case studies, and shorten the sales cycle for CGT manufacturing solutions.

ScaleReady Tech Stack

ScaleReady uses 8 technology products and services including LiteSpeed Cache, MySQL, Salesforce Marketing Cloud Account Engagement, and more. Explore ScaleReady's tech stack below.

  • LiteSpeed Cache
    Caching
  • MySQL
    Database
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • HubSpot
    Marketing Automation
  • Pantheon
    Platform As A Service
  • Adobe Acrobat DC
    Rich Text Editors
  • Nginx
    Web Servers
  • Draftpress HFCM
    Web Tools And Plugins

Media & News

ScaleReady's Email Address Formats

ScaleReady uses at least 1 format(s):
ScaleReady Email FormatsExamplePercentage
First.Last@scaleready.comJohn.Doe@scaleready.com
100%

Frequently Asked Questions

What is ScaleReady's official website and social media links?

Minus sign iconPlus sign icon
ScaleReady's official website is scaleready.com and has social profiles on LinkedIn.

What is ScaleReady's SIC code NAICS code?

Minus sign iconPlus sign icon
ScaleReady's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ScaleReady have currently?

Minus sign iconPlus sign icon
As of July 2026, ScaleReady has approximately 7 employees across 2 continents, including North AmericaEurope. Key team members include Technical Account Manager, West Coast: A. S.. Explore ScaleReady's employee directory with LeadIQ.

What industry does ScaleReady belong to?

Minus sign iconPlus sign icon
ScaleReady operates in the Biotechnology Research industry.

What technology does ScaleReady use?

Minus sign iconPlus sign icon
ScaleReady's tech stack includes LiteSpeed CacheMySQLSalesforce Marketing Cloud Account EngagementHubSpotPantheonAdobe Acrobat DCNginxDraftpress HFCM.

What is ScaleReady's email format?

Minus sign iconPlus sign icon
ScaleReady's email format typically follows the pattern of First.Last@scaleready.com. Find more ScaleReady email formats with LeadIQ.

When was ScaleReady founded?

Minus sign iconPlus sign icon
ScaleReady was founded in 2020.
ScaleReady logo

ScaleReady

Biotechnology ResearchMinnesota, United States2-10 Employees

ScaleReady is a biotechnology research company based in St. Paul, Minnesota. It operates as a joint venture between Bio-Techne and Wilson Wolf, combining established cell culture and processing capabilities to support therapeutic developers in cell therapy manufacturing. The organization emphasizes creating a scalable, versatile platform for manufacturing processes related to cell activation, gene editing, and cell processing, aimed at simplifying production for CGT (cell and gene-modified) therapies. Its market consists of developers and researchers seeking practical, scalable manufacturing solutions for advanced therapies, addressing the need for efficient closed-system production. ScaleReady positions itself within the biotech manufacturing segment, leveraging partnerships and collaborative programs to advance CGT manufacturing capabilities. A notable recent development is the launch of initiatives such as the LEAN Cell & Gene event series and a grant program, reflecting ongoing efforts to expand access to scalable CGT manufacturing capabilities. ScaleReady is active in the broader industry through collaborations with organizations like MaxCyte and Verismo Therapeutics, highlighting its role in supporting the commercialization and development of cell therapies.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    ScaleReady's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    ScaleReady's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.